Compulsivity, impulsivity, and the DSM-5 process

CNS Spectrums

Volumn 19, Issue 1, 2014, Pages 62-68

  Berlin, Gregory S ^a   Hollander, Eric ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

cross cutting symptom domains; DSM 5; impulsivity; Keywords Compulsivity; RDoC

Indexed keywords

ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; AUTISM; BODY DYSMORPHIC DISORDER; COMPULSION; CONDUCT DISORDER; DISEASE ASSOCIATION; DSM-5; FIELD STUDY; GILLES DE LA TOURETTE SYNDROME; HUMAN; HYPOCHONDRIASIS; ICD-11; IMPULSE CONTROL DISORDER; OBSESSIVE COMPULSIVE DISORDER; PATHOLOGICAL GAMBLING; PERSEVERATION; PERSONALITY DISORDER; PRIORITY JOURNAL; REVIEW; RITUAL; STRATEGIC PLANNING; SUBSTANCE ABUSE; TRICHOTILLOMANIA; CLINICAL FEATURE; COMORBIDITY; CONCEPTUAL FRAMEWORK; DISEASE CLASSIFICATION; HEALTH CARE PLANNING; IMPULSIVENESS; LITERATURE; NATIONAL HEALTH ORGANIZATION; OBSESSIVE COMPULSIVE RELATED DISORDER; PARAMEDICAL PERSONNEL; RESEARCH DOMAIN CRITERIA; RESEARCH PLANNING AGENDA; WORKGROUP;

ANIMALS; COMPULSIVE BEHAVIOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; IMPULSIVE BEHAVIOR; INTERNATIONAL CLASSIFICATION OF DISEASES; OBSESSIVE-COMPULSIVE DISORDER;

EID: 84896720883     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852913000722     Document Type: Review

References (41)

1. Robbins T, Curran H, De Wit H. Special issue on impulsivity and compulsivity. Psychopharmacology (Berl). 2012;219(2):251-252.
2. Meda SA, Stevens MC, Potenza MN, et al. Investigating the behavioral and self-report constructs of impulsivity domains using principal component analysis. Behav Pharmacol. 2009;20(5-6):390-399.
3. Dalley JW, Everitt BJ, Robbins TW. Impulsivity, compulsivity, and top-down cognitive control. Neuron. 2011;69(4):680-694.
4. Robbins TW, Gillan CM, Smith DG, De Wit S, Ersche KD. Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry. Trends Cogn Sci. 2012;16(1):81-91.
5. Fibbe LA, Cath DC, Van Den Heuvel OA, et al. Relationship between movement disorders and obsessive-compulsive disorder: beyond the obsessive-compulsive-tic phenotype. A systematic review. J Neurol Neurosurg Psychiatry.. 2012;83(6):646-654.
6. El-Guebaly N, Mudry T, Zohar J, Tavares H, Potenza MN. Compulsive features in behavioural addictions: the case of pathological gambling. Addiction. 2012;107(10):1726-1734.
7. Kashyap H, Fontenelle LF, Miguel EC, et al. "Impulsive compulsivity" in obsessive-compulsive disorder: a phenotypic marker of patients with poor clinical outcome. J Psychiatr Res. 2012;46(9):1146-1152.
8. Hollander E, Wong CM. Obsessive-compulsive spectrum disorders. JClin Psychiatry. 1995;56(Suppl 4):3-6; discussion 53-55.
9. Hollander E, Rosen J. Impulsivity. J Psychopharmacol. 2000;14(2 Suppl 1):S39-S44.
10. Hollander E, Zohar J, Sirovatka PJ, Regier DA. Obsessive-Compulsive Spectrum Disorders: Refining the Research Agenda for DSM-5. Arlington, VA: American Psychiatric Association; 2011.
11. Zohar J. Obsessive-Compulsive Disorder: Current Science and Clinical Practice. West Sussex, UK: Wiley-Blackwell; 2012.
12. American Psychiatric Association. Research Planning Launch/Methods Conference. APA Website. 2013. Available at http://www.dsm5.org/Research/Pages/ ResearchPlanningLaunchMethods Conference%28February18-20, 2004%29.aspx. Accessed March 27, 2013.
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association; 2000.
14. Potenza MN. Review. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Philos Trans R Soc Lond B Biol Sci. 2008;363(1507):3181-3189.
15. Peles E, Schreiber S, Sutzman A, Adelson M. Attention deficit hyperactivity disorder and obsessive-compulsive disorder among former heroin addicts currently in methadone maintenance treatment. Psychopathology. 2012;45(5):327-333.
16. McElroy SL, Soutullo CA, Beckman DA, Taylor P Jr, Keck PE Jr. DSM-IV intermittent explosive disorder: a report of 27 cases. J Clin Psychiatry. 1998;59(4):203-210; quiz 211.
17. Hollander E, King A, Delaney K, Smith CJ, Silverman JM. Obsessive-compulsive behaviors in parents of multiplex autism families. Psychiatry Res. 2003;117(1):11-16.
18. Fineberg NA, Potenza MN, Chamberlain SR, et al. Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review. Neuropsychopharmacology. 2010;35(3):591-604.
19. Graybiel AM. Network-level neuroplasticity in cortico-basal ganglia pathways. Parkinsonism Relat Disord. 2004;10(5):293-296.
20. Leonard HL, Swedo SE, Rapoport JL, et al. Treatment of obsessivecompulsive disorder with clomipramine and desipramine in children and adolescents: a double-blind crossover comparison. Arch Gen Psychiatry. 1989;46(12):1088-1092.
21. Hollander E, Allen A, Kwon J, et al. Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. Arch Gen Psychiatry. 1999;56(11):1033-1039.
22. Huh J, Goebert D, Takeshita J, Lu BY, Kang M. Treatment of generalized anxiety disorder: a comprehensive review of the literature for psychopharmacologic alternatives to newer antidepressants and benzodiazepines. Prim Care Companion CNS Disord. 2011;13(2):PCC.08r00709.
23. Kalus O, Asnis GM, Rubinson E, et al. Desipramine treatment in panic disorder. J Affect Disord. 1991;21(4):239-244.
24. McDougle CJ, Goodman WK, Price LH. The pharmacotherapy of obsessive-compulsive disorder. Pharmacopsychiatry. 1993;26(Suppl 1):24-29.
25. Kolevzon A, Mathewson KA, Hollander E. Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability. J Clin Psychiatry. 2006;67(3):407-414.
26. Hollander E, Phillips A, Chaplin W, et al. A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism. Neuropsychopharmacology. 2005;30(3):582-589.
27. Hollander E, Soorya L, Chaplin W, et al. A double-blind placebocontrolled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry. 2012;169(3):292-299.
28. American Psychiatric Association. DSM-5 development: DSM-5 timeline. 2012. Available at: http://www.dsm5.org/about/Pages/Timeline.aspx. Accessed March 27, 2013.
29. American Psychiatric Association. DSM-5 development: Why is the DSM being revised? 2013. Available at: http://www.dsm5.org/about/Pages/faq.aspx. Accessed March 24, 2013.
30. Wittchen HU, Gloster AT, Beesdo-Baum K, Fava GA, Craske MG. Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety. 2010;27(2):113-133.
31. Phillips KA, Stein DJ, Rauch SL, et al. Should an obsessivecompulsive spectrum grouping of disorders be included in DSM-5? Depress Anxiety. 2010;27(6):528-555.
32. American Psychiatric Association. DSM-5 development: Appendix B: Protocol for DSM-5 field trials in academic/large clinic settings [serial online]. 2010. Available at: http://www.dsm5.org/Documents/ Revised%20Field%20Trial%20Protocol%20for%20Large%20Clinical%20Settings-042910- II.pdf. Accessed March 24, 2013.
33. Clarke DE, Narrow WE, Regier DA, et al. DSM-5 field trials in the United States and Canada, part I: study design, sampling strategy, implementation, and analytic approaches. Am J Psychiatry. 2013;170(1):43-58.
34. Krueger RF, Derringer J, Markon KE, Watson D, Skodol AE. Initial construction of a maladaptive personality trait model and inventory for DSM-5. Psychol Med. 2012;42(9):1879-1890.
35. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Association; 2013.
36. American Psychiatric Association. DSM-5 development: obsessive compulsive disorders fact sheet. Available at: http://www.dsm5.org/Documents/ Obsessive%20Compulsive %20Disorders%20Fact%20Sheet.pdf. Accessed July 27, 2013.
37. American Psychiatric Association. DSM-5 development: DSM-5 draft criteria draws nearly 2, 300 responses. 2013. Available at: http://www.dsm5.org/ Documents/12-30%20Final%20DSM %20Public%20Comment.pdf. Accessed April 25, 2013.
38. National Institute of Mental Health. Research domain criteria. NIMH Web site. 2013. Available at: http://www.nimh.nih.gov/research-funding/rdoc/index. shtml. Accessed April 7, 2013.
39. Cuthbert BN, Insel TR. Toward the future of psychiatric diagnosis: the seven pillars of RDoC. BMC Med. 2013;11:126.
40. Morris SE, Cuthbert BN. Research Domain Criteria: cognitive systems, neural circuits, and dimensions of behavior. Dialogues Clin Neurosci. 2012;14(1):29-37.
41. Organization, WH. Classifications: International Classification of Diseases. WHO Web site. 2013. Available at: http://www.who.int/classifications/ icd/en/. Accessed March 27, 2013.